David Kirn

David Kirn

Founder bij 4D MOLECULAR THERAPEUTICS, INC.

Vermogen: 34 M $ op 31-03-2024

62 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

David H.
Kirn
was the founder of SillaJen Biotherapeutics, Inc. (founded in 2006) and 4D Molecular Therapeutics, Inc. (founded in 2013), where he holds the titles of President & Chief Medical Officer and Chief Executive Officer & Director, respectively.
Dr. Kirn is also the founder of Ignite Immunotherapy, Inc. Dr. Kirn's current jobs include Director at Coagulant Therapeutics, Inc. and Professor at the University of Oxford.
Dr. Kirn's former jobs include Principal at Warner-Lambert Co., Principal at Onyx Pharmaceuticals, Inc., Member at Harvard University, Faculty Member at The University of California, San Francisco, Advisor at National Institutes of Health, Principal at IP2IPO Innovations Ltd., and Faculty Member at Specialist Diabetes Research & Treatment Centre LLC.
Dr. Kirn obtained his undergraduate degree from the University of California, Berkeley in 1985 and his doctorate degree from The University of California, San Francisco in 1989.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
08-02-2024 1 059 153 ( 2.13% ) 34 M $ 31-03-2024

Actieve functies van David Kirn

BedrijvenFunctieBegin
4D MOLECULAR THERAPEUTICS, INC. Founder 12-09-2013
University of Oxford Corporate Officer/Principal -
Director/Board Member -
Alle actieve functies van David Kirn

Eerdere bekende functies van David Kirn

BedrijvenFunctieEinde
Founder 01-01-2019
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
The University of California, San Francisco Corporate Officer/Principal -
Ervaring van David Kirn in detail bekijken

Opleiding van David Kirn

University of California, Berkeley Undergraduate Degree
The University of California, San Francisco Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van David Kirn in detail bekijken

Connecties

100 +

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
4D MOLECULAR THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit8

Health Technology

Health Technology

Commercial Services

Government

Commercial Services

Health Services

Health Technology

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. David Kirn